Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Contributions to Nephrology
|
June 9, 2001
Should we target signal pathways instead of single mediators in the treatment of sepsis?
M L Wratten, A Brendolan, C Ronco, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 31, 1997
Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments
C Tetta, F Mariano, J Buades, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
March 5, 2005
[Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins]
M L Wratten, L Sereni, M Lupotti, et al.
Blood Purification
|
August 18, 1999
An overview of haemodialysis and oxidant stress
C Tetta, S Biasioli, R Schiavon, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
March 5, 2005
[Contact phase activation can occur with certain types of activated carbon]
M Atti, M L Wratten, A Sereni, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|
May 20, 2003
New perspectives in hemodialytic strategies
C Tetta, C De Nitti, M L Wratten, et al.
Blood Purification
|
August 18, 1999
Uremic ultrafiltrate inhibits platelet-activating factor synthesis
M L Wratten, C Tetta, R De Smet, et al.
Contributions to Nephrology
|
August 2, 2001
Use of sorbents in acute renal failure and sepsis
C Ronco, A Brendolan, M Dan, et al.
Contributions to Nephrology
|
July 10, 2002
Use of adsorbents in ARF therapy
C Tetta, R Bellomo, M Formica, et al.
The International Journal of Artificial Organs
|
February 17, 1998
In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes
S Mandolfo, C Tetta, S David, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Contributions to Nephrology
|
June 9, 2001
Should we target signal pathways instead of single mediators in the treatment of sepsis?
M L Wratten, A Brendolan, C Ronco, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 31, 1997
Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments
C Tetta, F Mariano, J Buades, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
March 5, 2005
[Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins]
M L Wratten, L Sereni, M Lupotti, et al.
Blood Purification
|
August 18, 1999
An overview of haemodialysis and oxidant stress
C Tetta, S Biasioli, R Schiavon, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
March 5, 2005
[Contact phase activation can occur with certain types of activated carbon]
M Atti, M L Wratten, A Sereni, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|
May 20, 2003
New perspectives in hemodialytic strategies
C Tetta, C De Nitti, M L Wratten, et al.
Blood Purification
|
August 18, 1999
Uremic ultrafiltrate inhibits platelet-activating factor synthesis
M L Wratten, C Tetta, R De Smet, et al.
Contributions to Nephrology
|
August 2, 2001
Use of sorbents in acute renal failure and sepsis
C Ronco, A Brendolan, M Dan, et al.
Contributions to Nephrology
|
July 10, 2002
Use of adsorbents in ARF therapy
C Tetta, R Bellomo, M Formica, et al.
The International Journal of Artificial Organs
|
February 17, 1998
In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes
S Mandolfo, C Tetta, S David, et al.
Page
of 4